[Anti-platelet treatment in cardiology].
Antiplatelets are today one of the pivotal treatment in cardiovascular disease. Aspirin, used for more than 100 years, continue to be the most used drug in the treatment of athe rosclerosis. However, new antiplatelet molecules such as clopidogrel and antibodies against glycoprotein IIb-IIIa are now part of the daily treatment for the general as well for the interventional cardiologist. This paper is a review of these different compounds in the light of the huge data available in the literature.
De Benedetti
E
E
Département de Cardiologie, Hôpital de la Tour, Meyrin-Genève. edb@latour.ch
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D015607:Stents
D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex